Activities of LpxC inhibitors as a function of the resistance phenotype in Enterobacteriaceae, P. aeruginosa and A. baumannii
Organism group (number tested) . | MIC (mg/L) . | LPC-058 . | LPC-011 . | LPC-087 . | CHIR-090 . |
---|---|---|---|---|---|
Enterobacteriaceae non-MDR/XDR (196) | MIC50 | 0.06 | 0.12 | 0.25 | 0.5 |
MIC90 | 0.12 | 0.25 | 0.5 | 1 | |
range | ≤0.015–0.25 | ≤0.015–1 | ≤0.015–1 | 0.03–2 | |
Enterobacteriaceae MDR or XDR (38a) | MIC50 | 0.06 | 0.12 | 0.25 | 0.5 |
MIC90 | 0.25 | 0.5 | 1 | 2 | |
range | ≤0.015–0.25 | 0.06–1 | 0.25–1 | 0.25–8 | |
P. aeruginosa non-MDR/XDR (31) | MIC50 | 0.25 | 0.5 | 2 | 2 |
MIC90 | 0.5 | 1 | 4 | 4 | |
range | 0.06–0.5 | 0.25–2 | 0.25–4 | 0.5–8 | |
P. aeruginosa MDR or XDR (20b) | MIC50 | 0.25 | 0.5 | 4 | 4 |
MIC90 | 0.5 | 1 | 8 | 8 | |
range | 0.12–0.5 | 0.25–1 | 1–8 | 2–8 | |
A. baumannii non-MDR/XDR (6) | MIC50 | 0.25 | ≥64 | 1 | ≥64 |
MIC90 | 0.5 | ≥64 | 2 | ≥64 | |
range | 0.12–0.5 | ≥64 | 0.5–2 | ≥64 | |
A. baumannii MDR or XDR (20c) | MIC50 | 0.25 | ≥64 | 1 | ≥64 |
MIC90 | 1 | ≥64 | 32 | ≥64 | |
range | 0.12–4 | ≥64 | 0.5 to ≥64 | ≥64 |
Organism group (number tested) . | MIC (mg/L) . | LPC-058 . | LPC-011 . | LPC-087 . | CHIR-090 . |
---|---|---|---|---|---|
Enterobacteriaceae non-MDR/XDR (196) | MIC50 | 0.06 | 0.12 | 0.25 | 0.5 |
MIC90 | 0.12 | 0.25 | 0.5 | 1 | |
range | ≤0.015–0.25 | ≤0.015–1 | ≤0.015–1 | 0.03–2 | |
Enterobacteriaceae MDR or XDR (38a) | MIC50 | 0.06 | 0.12 | 0.25 | 0.5 |
MIC90 | 0.25 | 0.5 | 1 | 2 | |
range | ≤0.015–0.25 | 0.06–1 | 0.25–1 | 0.25–8 | |
P. aeruginosa non-MDR/XDR (31) | MIC50 | 0.25 | 0.5 | 2 | 2 |
MIC90 | 0.5 | 1 | 4 | 4 | |
range | 0.06–0.5 | 0.25–2 | 0.25–4 | 0.5–8 | |
P. aeruginosa MDR or XDR (20b) | MIC50 | 0.25 | 0.5 | 4 | 4 |
MIC90 | 0.5 | 1 | 8 | 8 | |
range | 0.12–0.5 | 0.25–1 | 1–8 | 2–8 | |
A. baumannii non-MDR/XDR (6) | MIC50 | 0.25 | ≥64 | 1 | ≥64 |
MIC90 | 0.5 | ≥64 | 2 | ≥64 | |
range | 0.12–0.5 | ≥64 | 0.5–2 | ≥64 | |
A. baumannii MDR or XDR (20c) | MIC50 | 0.25 | ≥64 | 1 | ≥64 |
MIC90 | 1 | ≥64 | 32 | ≥64 | |
range | 0.12–4 | ≥64 | 0.5 to ≥64 | ≥64 |
aIncludes 17 ESBL-producing and 5 carbapenemase-producing strains [OXA-48 (n = 3), NDM (n = 1) and KPC (n = 1)].
bIncludes three ESBL-producing and five carbapenemase-producing strains [VIM (n = 4) and IMP (n = 1)].
cIncludes 1 ESBL-producing and 10 carbapenemase-producing strains [OXA-23 (n = 9) and OXA-40 (n = 1)].
Activities of LpxC inhibitors as a function of the resistance phenotype in Enterobacteriaceae, P. aeruginosa and A. baumannii
Organism group (number tested) . | MIC (mg/L) . | LPC-058 . | LPC-011 . | LPC-087 . | CHIR-090 . |
---|---|---|---|---|---|
Enterobacteriaceae non-MDR/XDR (196) | MIC50 | 0.06 | 0.12 | 0.25 | 0.5 |
MIC90 | 0.12 | 0.25 | 0.5 | 1 | |
range | ≤0.015–0.25 | ≤0.015–1 | ≤0.015–1 | 0.03–2 | |
Enterobacteriaceae MDR or XDR (38a) | MIC50 | 0.06 | 0.12 | 0.25 | 0.5 |
MIC90 | 0.25 | 0.5 | 1 | 2 | |
range | ≤0.015–0.25 | 0.06–1 | 0.25–1 | 0.25–8 | |
P. aeruginosa non-MDR/XDR (31) | MIC50 | 0.25 | 0.5 | 2 | 2 |
MIC90 | 0.5 | 1 | 4 | 4 | |
range | 0.06–0.5 | 0.25–2 | 0.25–4 | 0.5–8 | |
P. aeruginosa MDR or XDR (20b) | MIC50 | 0.25 | 0.5 | 4 | 4 |
MIC90 | 0.5 | 1 | 8 | 8 | |
range | 0.12–0.5 | 0.25–1 | 1–8 | 2–8 | |
A. baumannii non-MDR/XDR (6) | MIC50 | 0.25 | ≥64 | 1 | ≥64 |
MIC90 | 0.5 | ≥64 | 2 | ≥64 | |
range | 0.12–0.5 | ≥64 | 0.5–2 | ≥64 | |
A. baumannii MDR or XDR (20c) | MIC50 | 0.25 | ≥64 | 1 | ≥64 |
MIC90 | 1 | ≥64 | 32 | ≥64 | |
range | 0.12–4 | ≥64 | 0.5 to ≥64 | ≥64 |
Organism group (number tested) . | MIC (mg/L) . | LPC-058 . | LPC-011 . | LPC-087 . | CHIR-090 . |
---|---|---|---|---|---|
Enterobacteriaceae non-MDR/XDR (196) | MIC50 | 0.06 | 0.12 | 0.25 | 0.5 |
MIC90 | 0.12 | 0.25 | 0.5 | 1 | |
range | ≤0.015–0.25 | ≤0.015–1 | ≤0.015–1 | 0.03–2 | |
Enterobacteriaceae MDR or XDR (38a) | MIC50 | 0.06 | 0.12 | 0.25 | 0.5 |
MIC90 | 0.25 | 0.5 | 1 | 2 | |
range | ≤0.015–0.25 | 0.06–1 | 0.25–1 | 0.25–8 | |
P. aeruginosa non-MDR/XDR (31) | MIC50 | 0.25 | 0.5 | 2 | 2 |
MIC90 | 0.5 | 1 | 4 | 4 | |
range | 0.06–0.5 | 0.25–2 | 0.25–4 | 0.5–8 | |
P. aeruginosa MDR or XDR (20b) | MIC50 | 0.25 | 0.5 | 4 | 4 |
MIC90 | 0.5 | 1 | 8 | 8 | |
range | 0.12–0.5 | 0.25–1 | 1–8 | 2–8 | |
A. baumannii non-MDR/XDR (6) | MIC50 | 0.25 | ≥64 | 1 | ≥64 |
MIC90 | 0.5 | ≥64 | 2 | ≥64 | |
range | 0.12–0.5 | ≥64 | 0.5–2 | ≥64 | |
A. baumannii MDR or XDR (20c) | MIC50 | 0.25 | ≥64 | 1 | ≥64 |
MIC90 | 1 | ≥64 | 32 | ≥64 | |
range | 0.12–4 | ≥64 | 0.5 to ≥64 | ≥64 |
aIncludes 17 ESBL-producing and 5 carbapenemase-producing strains [OXA-48 (n = 3), NDM (n = 1) and KPC (n = 1)].
bIncludes three ESBL-producing and five carbapenemase-producing strains [VIM (n = 4) and IMP (n = 1)].
cIncludes 1 ESBL-producing and 10 carbapenemase-producing strains [OXA-23 (n = 9) and OXA-40 (n = 1)].
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.